Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

1.97
Delayed Data
As of Jun 27
 -0.03 / -1.50%
Today’s Change
1.24
Today|||52-Week Range
2.59
+4.23%
Year-to-Date
This Tiny Biopharma Has Been Bucking The Downtrend
Jun 27 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.00
Today’s open1.99
Day’s range1.90 - 2.01
Volume1,588,727
Average volume (3 months)915,573
Market cap$366.2M
Dividend yield--
Data as of 4:00pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+6.25%
Earnings growth (next 5 years)+207.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...-0.45-3.23%
SGMOSangamo BioSciences ...-0.37-6.72%
ARWRArrowhead Pharmaceut...-0.33-6.03%
ENZEnzo Biochem Inc-0.13-2.25%
Data as of 4:01pm ET, 06/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
VP-Finance &
Principal Accounting Officer
Michael J. Farrell
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs